Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 435,321 | 507,144 | 351,047 | 137,184 | 207,537 |
| Marketable Securities | 977,827 | 962,553 | 610,154 | 412,397 | 379,713 |
| Other current assets | 2,511 | 5,674 | 0 | 0 | 0 |
| TOTAL | $1,431,622 | $1,495,655 | $970,866 | $559,409 | $604,785 |
| Non-Current Assets | |||||
| PPE Net | 41,376 | 40,846 | 42,265 | 43,622 | 45,452 |
| Investments And Advances | 38,885 | 32,699 | 20,341 | 7,229 | 9,684 |
| Other Non-Current Assets | 35,975 | 35,080 | 36,834 | 37,077 | 35,944 |
| TOTAL | $116,236 | $108,625 | $99,440 | $87,928 | $91,080 |
| Total Assets | $1,547,858 | $1,604,280 | $1,070,306 | $647,337 | $695,865 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,626 | 1,071 | 2,806 | 1,866 | 2,316 |
| Accrued Expenses | 26,690 | 47,145 | 4,689 | 4,179 | 5,349 |
| Other current liabilities | 21,418 | 23,483 | 93,410 | 48,089 | 35,849 |
| TOTAL | $54,610 | $71,699 | $105,413 | $58,464 | $47,635 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 387,895 | 382,050 | 82,343 | 86,706 | 102,919 |
| TOTAL | $387,895 | $382,050 | $82,343 | $86,706 | $102,919 |
| Total Liabilities | $442,505 | $453,749 | $187,756 | $145,170 | $150,554 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 121,192 | 120,984 | 119,919 | 105,983 | 105,628 |
| Common Shares | 1,537 | 1,531 | 1,524 | 1,385 | 1,382 |
| Retained earnings | -424,456 | -354,415 | -599,300 | -541,072 | -482,314 |
| Other shareholders' equity | -232 | -245 | 11 | 551 | 835 |
| TOTAL | $1,105,353 | $1,150,531 | $882,550 | $502,167 | $545,311 |
| Total Liabilities And Equity | $1,547,858 | $1,604,280 | $1,070,306 | $647,337 | $695,865 |